Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Total Liabilities (2022 - 2025)

Historic Total Liabilities for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to $291.2 million.

  • Gossamer Bio's Total Liabilities fell 188.38% to $291.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $291.2 million, marking a year-over-year decrease of 188.38%. This contributed to the annual value of $285.8 million for FY2024, which is 1471.14% up from last year.
  • According to the latest figures from Q3 2025, Gossamer Bio's Total Liabilities is $291.2 million, which was down 188.38% from $287.0 million recorded in Q2 2025.
  • In the past 5 years, Gossamer Bio's Total Liabilities registered a high of $296.7 million during Q3 2024, and its lowest value of $232.6 million during Q1 2024.
  • Its 4-year average for Total Liabilities is $267.5 million, with a median of $264.5 million in 2022.
  • As far as peak fluctuations go, Gossamer Bio's Total Liabilities plummeted by 893.72% in 2023, and later surged by 2329.84% in 2025.
  • Gossamer Bio's Total Liabilities (Quarter) stood at $260.4 million in 2022, then decreased by 4.31% to $249.1 million in 2023, then grew by 14.71% to $285.8 million in 2024, then grew by 1.87% to $291.2 million in 2025.
  • Its Total Liabilities was $291.2 million in Q3 2025, compared to $287.0 million in Q2 2025 and $286.8 million in Q1 2025.